![](/img/cover-not-exists.png)
Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target
Abdelwahab, E. M. M., Pal, S., Kvell, K., Sarosi, V., Bai, P., Rue, R., Krymskaya, V., McPhail, D., Porter, A., Pongracz, J. E.Language:
english
Journal:
Oncogene
DOI:
10.1038/s41388-018-0625-1
Date:
December, 2018
File:
PDF, 2.70 MB
english, 2018